US Patent 7718192 Tamper-resistant oral opioid agonist formulations
Patent 7718192 was granted and assigned to Purdue Pharma on May, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+221 characters)
Article
Patent abstract
Disclosed is an oral dosage form comprising (i) an opioid agonist in releasable form and (ii) a sequestered opioid antagonist which is substantially not released when the dosage form is administered intact.
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07718192 Tamper-resistant oral opioid agonist formulations US Patent 7718192 Tamper-resistant oral opioid agonist formulations
Infobox
Patent Number
0771819200
Patent Number
771819200
Edits on 22 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
077181920
Date of Patent
May 18, 2010
0Patent Application Number
107008930
Date Filed
November 4, 2003
0Official Website
Patent Primary Examiner
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
077181920
Date of Patent
May 18, 2010
0Patent Application Number
107008930
Date Filed
November 4, 2003
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 4 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07718192 Tamper-resistant oral opioid agonist formulations
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07718192
Date of patent
May 18, 2010
Patent application number
10700893
Date Filed
November 4, 2003
Patent primary examiner
Find more entities like US Patent 7718192 Tamper-resistant oral opioid agonist formulations
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.